SAGA Metals Defines Key Structural Geology at Trapper South & Provides Corporate Update

SAGA Metals Defines Key Structural Geology at Trapper South & Provides Corporate Update GlobeNewswire December 17, 2025 VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company advancing critical mineral discoveries, is pleased to announce the full logging […]

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement GlobeNewswire December 17, 2025 Following closing, combined company plans to progress Yarrow's lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves' disease (“GD”) and thyroid eye disease (“TED”) Yarrow Bioscience is the seventh biotechnology company founded by RTW Investments and plans to advance

Enecom, Inc., a Japanese ICT Services Provider, Enhances Its Enterprise Data Infrastructure with the InfiniBox(R) Solution for 100% Availability and Cyber Resilient Storage

Enecom, Inc., a Japanese ICT Services Provider, Enhances Its Enterprise Data Infrastructure with the InfiniBox(R) Solution for 100% Availability and Cyber Resilient Storage GlobeNewswire December 17, 2025 WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) — Infinidat, a leading provider of enterprise storage solutions, today announced that Enecom, Inc., an information and communication technology (ICT) services

TadHealth Awarded San Diego County Office of Education Contract; School Districts to Begin CYBHI Billing in January 2026

TadHealth Awarded San Diego County Office of Education Contract; School Districts to Begin CYBHI Billing in January 2026 GlobeNewswire December 17, 2025 COSTA MESA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — TadHealth, a leading provider of school-based mental health technology, has been selected by the San Diego County Office of Education (SDCOE) to deliver a

SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D

SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D GlobeNewswire December 17, 2025 Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed healthy volunteers Study results support

Asia Broadband Corporate Update and Projects Status Scheduled For January 2026 and AABB Shareholders Merry Christmas

Asia Broadband Corporate Update and Projects Status Scheduled For January 2026 and AABB Shareholders Merry Christmas GlobeNewswire December 17, 2025 LAS VEGAS, Dec. 17, 2025 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is set to release a corporate update in January 2026. After

LifeSci Communications Promotes Ian Stone to Chief Executive Officer

LifeSci Communications Promotes Ian Stone to Chief Executive Officer LifeSci Partners continues West Coast growth with addition of San Diego office GlobeNewswire December 17, 2025 NEW YORK and SAN DIEGO, Dec. 17, 2025 (GLOBE NEWSWIRE) — LifeSci Communications today announced the promotion of Ian Stone to chief executive officer to guide the company's growth and

Gabelli Funds Now Offers Seven Fully Transparent ETF Strategies

Gabelli Funds Now Offers Seven Fully Transparent ETF Strategies GlobeNewswire December 17, 2025 GREENWICH, Conn., Dec. 17, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”) today announced that all its actively managed ETFs are now fully transparent. These Gabelli ETFs complement the firm's long-standing investment offerings across mutual funds, closed-end funds, and separate accounts –

E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation

E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — E.F. Hutton is proud to have served as an Exclusive M&A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS) and

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update GlobeNewswire December 17, 2025 DUBLIN and CHICAGO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today

Scroll to Top